P4820Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.